IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Hikma Acquires Stake in Indian API Firm

10:52 PM MDT | April 18, 2011 | Deepti Ramesh

Hikma Pharmaceuticals (London) says it has agreed to acquire a minority interest in privately held Unimark Remedies (Mumbai), a manufacturer of active pharmaceutical ingredients (API) and pharma intermediates, for $33.3 million. The transaction is expected to be completed next month. Unimark’s product range includes betalactams, cephalosporins, carbapenems and covers several therapeutic segments including cardiovascular, anti-asthma and anti-infectives. Unimark operates three API facilities, two of which are approved by the U.S. FDA, and two R&D...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa